SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-04-000857
Filing Date
2004-03-12
Accepted
2004-03-12 09:55:57
Documents
9
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K w94938e10vk.htm 10-K 868581
3 EXHIBIT 10.34 w94938exv10w34.htm EX-10.34 131492
4 EXHIBIT 21 w94938exv21.htm EX-21 1216
5 EXHIBIT 23.1 w94938exv23w1.htm EX-23.1 2340
6 EXHIBIT 23.2 w94938exv23w2.htm EX-23.2 2379
7 EXHIBIT 31.1 w94938exv31w1.htm EX-31.1 7863
8 EXHIBIT 31.2 w94938exv31w2.htm EX-31.2 8202
9 EXHIBIT 32.1 w94938exv32w1.htm EX-32.1 4180
10 EXHIBIT 32.2 w94938exv32w2.htm EX-32.2 4204
  Complete submission text file 0000950133-04-000857.txt   1032863
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26301 | Film No.: 04664329
SIC: 2834 Pharmaceutical Preparations